Between January 1, 2016 and December 31, 2019, 6060 patients with a personal or strong family history of cancer who were referred to a hereditary cancer clinic in Ontario on suspicion of a hereditary cancer syndrome consented to have NGS-MGP testing. This evidence concerns the gene MGP and Inherited cancer-predisposing syndrome.